XFRA NEW INSTRUMENTS AVAILABLE ON XETRA

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 09.10.2024

The following instruments on XETRA do have their first trading 09.10.2024
Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 09.10.2024

Aktien

1 US23381D1028 Daiichi Sankyo Co. Ltd. ADR
2 KYG392AS1011 Global New Material International Holdings Ltd.
3 US4928541048 Kewaunee Scientific Corp.
4 US00439U1043 Acasti Pharma Inc.

5 BMG4R86G1074 Gold Reserve Ltd.
6 SGXZ53070850 Hafnia Ltd.
7 SGXZ57724486 Maxeon Solar Technologies Ltd.
8 US8173233060 Sequans Communications S.A. ADR

Anleihen/ETF

1 XS2914770545 Kasachstan, Republik
2 BE0002219856 FLUXYS Belgium S.A.
3 DE000BU0E220 Deutschland, Bundesrepublik
4 ES0L02510102 Spanien, Königreich
5 ES0413860877 Banco de Sabadell S.A.
6 DE000HEL0AL9 Landesbank Hessen-Thüringen Girozentrale
7 DE000HLB44Y3 Landesbank Hessen-Thüringen Girozentrale
8 DE000HLB44X5 Landesbank Hessen-Thüringen Girozentrale
9 DE000HLB44Z0 Landesbank Hessen-Thüringen Girozentrale
10 IE000GBYNAU4 AXA IM ICE US Treasury +25Y UCITS ETF
11 LU2673522830 Xtrackers II Target Maturity Sept 2027 EUR Corporate Bond UCITS ETF
12 LU2673522913 Xtrackers II Target Maturity Sept 2029 EUR Corporate Bond UCITS ETF
13 LU2673523135 Xtrackers II Target Maturity Sept 2031 EUR Corporate Bond UCITS ETF
14 LU2673523051 Xtrackers II Target Maturity Sept 2033 EUR Corporate Bond UCITS ETF

Zeit	Aktuelle Nachrichten
31.03.	GLOBAL NEW MAT (06616): ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 AND CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING
31.03.	GLOBAL NEW MAT (06616): FURTHER DELAY IN DESPATCH OF CIRCULAR
19.03.	GLOBAL NEW MAT (06616): NOTICE OF BOARD MEETING
28.02.	GLOBAL NEW MAT (06616): RESULTS OF A SUBSIDIARY
08.11.24	GLOBAL NEW MAT (06616): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROPOSED ISSUE OF CONVERTIBLE BONDS OF UP TO US$80,000,000 UNDER GENERAL MANDATE

Zeit

Aktuelle Nachrichten

31.03.

GLOBAL NEW MAT (06616): ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 AND CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING

31.03.

GLOBAL NEW MAT (06616): FURTHER DELAY IN DESPATCH OF CIRCULAR

19.03.

GLOBAL NEW MAT (06616): NOTICE OF BOARD MEETING

28.02.

GLOBAL NEW MAT (06616): RESULTS OF A SUBSIDIARY

08.11.24

GLOBAL NEW MAT (06616): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROPOSED ISSUE OF CONVERTIBLE BONDS OF UP TO US$80,000,000 UNDER GENERAL MANDATE

Zeit	Aktuelle Nachrichten
Di	Gold Reserve Ltd: Gold Reserve's Citgo sale objections fall on deaf ears
17.04.	Gold Reserve Ltd: Gold Reserve objections for Citgo sale may be overruled
14.04.	Gold Reserve Ltd: Gold Reserve completes prehearing documents for hearing
07.04.	Gold Reserve Ltd: Gold Reserve to plead against Red Tree's Citgo bid
04.04.	Gold Reserve Ltd: Gold Reserve files lawsuits to execute against accounts

Zeit

Aktuelle Nachrichten

Gold Reserve Ltd: Gold Reserve's Citgo sale objections fall on deaf ears

17.04.

Gold Reserve Ltd: Gold Reserve objections for Citgo sale may be overruled

14.04.

Gold Reserve Ltd: Gold Reserve completes prehearing documents for hearing

07.04.

Gold Reserve Ltd: Gold Reserve to plead against Red Tree's Citgo bid

04.04.

Gold Reserve Ltd: Gold Reserve files lawsuits to execute against accounts

Zeit	Aktuelle Nachrichten
09.04.	Grace Therapeutics aligns with FDA on GTx-104 NDA submission
09.04.	Grace Therapeutics einigt sich mit FDA über GTx-104 NDA-Einreichung
09.04.	Grace Therapeutics, Inc.: Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104	PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage... ► Artikel lesen
09.04.	Grace Therapeutics, Inc. - 8-K, Current Report
03.03.	Grace Therapeutics, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

09.04.

Grace Therapeutics aligns with FDA on GTx-104 NDA submission

09.04.

Grace Therapeutics einigt sich mit FDA über GTx-104 NDA-Einreichung

09.04.

Grace Therapeutics, Inc.: Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104

PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage...
► Artikel lesen

09.04.

Grace Therapeutics, Inc. - 8-K, Current Report

03.03.

Grace Therapeutics, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
15.04.	Hafnia Ltd - 6-K, Report of foreign issuer
15.04.	HAFNIA LIMITED: Annual General Meeting - Notice
20.03.	Hafnia introduces FuelSure platform to enhance transparency in bunker fuel market
19.03.	Hafnia Ltd - 6-K, Report of foreign issuer
19.03.	HAFNIA LIMITED: Resignation of Board Member

Zeit

Aktuelle Nachrichten

15.04.

Hafnia Ltd - 6-K, Report of foreign issuer

15.04.

HAFNIA LIMITED: Annual General Meeting - Notice

20.03.

Hafnia introduces FuelSure platform to enhance transparency in bunker fuel market

19.03.

Hafnia Ltd - 6-K, Report of foreign issuer

19.03.

HAFNIA LIMITED: Resignation of Board Member

Zeit	Aktuelle Nachrichten
11.04.	Kewaunee Scientific Chief Financial Officer Sold $148K In Company Stock
14.03.	KEWAUNEE SCIENTIFIC CORP /DE/ - 10-Q, Quarterly Report
12.03.	Kewaunee Scientific Corporation: Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025	STATESVILLE, N.C., March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January... ► Artikel lesen
12.03.	Kewaunee Scientific Non-GAAP EPS of $1.09, revenue of $67.17M
12.03.	KEWAUNEE SCIENTIFIC CORP /DE/ - 8-K, Current Report

Zeit

Aktuelle Nachrichten

11.04.

Kewaunee Scientific Chief Financial Officer Sold $148K In Company Stock

14.03.

KEWAUNEE SCIENTIFIC CORP /DE/ - 10-Q, Quarterly Report

12.03.

Kewaunee Scientific Corporation: Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

STATESVILLE, N.C., March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January...
► Artikel lesen

12.03.

Kewaunee Scientific Non-GAAP EPS of $1.09, revenue of $67.17M

12.03.

KEWAUNEE SCIENTIFIC CORP /DE/ - 8-K, Current Report

Zeit	Aktuelle Nachrichten
08.04.	CBP denies Maxeon's protests against detention of modules, Maxeon to 'establish alternative' supply chains
07.04.	Maxeon Solar rises on plans for alternative supply chains due to tariff chaos
05.04.	Maxeon Solar shifts focus to U.S. market amid challenges
04.04.	Maxeon Solar Technologies, Ltd. - 6-K, Report of foreign issuer
04.04.	Maxeon Solar Technologies, Ltd.: Maxeon Provides Strategic Business Update	SINGAPORE, April 4, 2025 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN), a global leader in solar innovation and channels, today provided an... ► Artikel lesen

Zeit

Aktuelle Nachrichten

08.04.

CBP denies Maxeon's protests against detention of modules, Maxeon to 'establish alternative' supply chains

07.04.

Maxeon Solar rises on plans for alternative supply chains due to tariff chaos

05.04.

Maxeon Solar shifts focus to U.S. market amid challenges

04.04.

Maxeon Solar Technologies, Ltd. - 6-K, Report of foreign issuer

04.04.

Maxeon Solar Technologies, Ltd.: Maxeon Provides Strategic Business Update

SINGAPORE, April 4, 2025 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN), a global leader in solar innovation and channels, today provided an...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Di	Sequans Communications: Sequans Announces Conference Call to Review First Quarter 2025 Results	Paris, France--(Newsfile Corp. - April 22, 2025) - Sequans Communications S.A. (NYSE: SQNS), a leading provider of 4G and 5G semiconductors and modules for the Internet of Things, will release its... ► Artikel lesen
03.04.	Sequans Communications regains compliance with NYSE
03.04.	Sequans meets NYSE listing standards after strategic moves
03.04.	Sequans Communications Regains NYSE Listing Compliance	Paris, France--(Newsfile Corp. - April 3, 2025) - Sequans Communications S.A. (NYSE: SQNS), a leading provider of 4G and 5G semiconductors and modules for the Internet of Things, announced today that... ► Artikel lesen
03.04.	SEQUANS COMMUNICATIONS - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten

Sequans Communications: Sequans Announces Conference Call to Review First Quarter 2025 Results

Paris, France--(Newsfile Corp. - April 22, 2025) - Sequans Communications S.A. (NYSE: SQNS), a leading provider of 4G and 5G semiconductors and modules for the Internet of Things, will release its...
► Artikel lesen

03.04.

Sequans Communications regains compliance with NYSE

03.04.

Sequans meets NYSE listing standards after strategic moves

03.04.

Sequans Communications Regains NYSE Listing Compliance

Paris, France--(Newsfile Corp. - April 3, 2025) - Sequans Communications S.A. (NYSE: SQNS), a leading provider of 4G and 5G semiconductors and modules for the Internet of Things, announced today that...
► Artikel lesen

03.04.

SEQUANS COMMUNICATIONS - 6-K, Report of foreign issuer

Unternehmen / Aktien	Kurs	%
GLOBAL NEW MATERIAL INTERNATIONAL HOLDINGS LTD	0,396	0,00 %
GOLD RESERVE LTD	1,410	+8,46 %
GRACE THERAPEUTICS INC	2,350	+2,17 %
HAFNIA LIMITED	3,942	+0,28 %
KEWAUNEE SCIENTIFIC CORPORATION	29,600	0,00 %
MAXEON SOLAR TECHNOLOGIES LTD	2,980	-1,97 %
SEQUANS COMMUNICATIONS SA ADR	1,955	0,00 %

Unternehmen / Aktien

Kurs

GLOBAL NEW MATERIAL INTERNATIONAL HOLDINGS LTD

0,396

0,00 %

GOLD RESERVE LTD

1,410

+8,46 %

GRACE THERAPEUTICS INC

2,350

+2,17 %

HAFNIA LIMITED